We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Translational Science With Clinical Promise | ONLINE FIRST

Introducing “Translational Science With Clinical Promise”

Marco Zarbin, MD, PhD
Arch Ophthalmol. 2012;130(8):1063-1064. doi:10.1001/archophthalmol.2012.2199.
Text Size: A A A
Published online


I am very pleased to introduce “Translational Science with Clinical Promise” to the readers of Archives of Ophthalmology. Translational science involves research in which one applies established knowledge, often from unexpected disciplines, to develop novel therapeutic or diagnostic technology. It is not necessarily focused on the discovery of basic biological principles or mechanisms. Translational science tends to be multidisciplinary. Diverse fields of knowledge must be coordinated because developing clinical treatments is like solving multivariate equations. Many variables have to be identified and optimized to arrive at a solution that is useful clinically. For example, the development of a light-adjustable intraocular lens requires expertise in polymer chemistry, optics, manufacturing, clinical trial design, regulatory affairs, and anterior segment surgery. This multidisciplinary approach is indispensable to product development in the 21st century. The complexity inherent in translational science is mostly hidden inside large companies, which employ medicinal chemists, physicians, statisticians, epidemiologists, and basic scientists. Traditionally in ophthalmology, many of the exciting developments in translational research have been published in the trade journals. There has not been a peer-reviewed journal primarily focused on the most promising emerging therapies and diagnostics in our field until now.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles